Previous Article | Next Article 
Journal of Clinical Microbiology, May 1999, p. 1340-1347, Vol. 37, No. 5
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
GB Virus C/Hepatitis G Virus Groups and Subgroups: Classification
by a Restriction Fragment Length Polymorphism Method Based on
Phylogenetic Analysis of the 5' Untranslated Region
J. F.
Quarleri,1,2
V. L.
Mathet,1,2
M.
Feld,1
D.
Ferrario,1
M. P.
della
Latta,1
R.
Verdun,3
D. O.
Sánchez,3 and
J. R.
Oubiña1,2,*
Laboratorio de Hepatitis Virales,
Departamento Microbiología, Facultad de Medicina, Universidad
de Buenos Aires,1 Facultad de
Medicina, Universidad del Salvador,2 and
Instituto de Investigaciones Biotecnológicas,
Universidad de San Martín,3 Buenos
Aires, Argentina
Received 28 August 1998/Returned for modification 19 November
1998/Accepted 27 January 1999
 |
ABSTRACT |
A phylogenetic tree based on 150 5' untranslated region sequences
deposited in GenBank database allowed segregation of the sequences into
three major groups, including two subgroups, i.e., 1, 2a, 2b, and
3, supported by bootstrap analysis. Restriction site analysis of these
sequences predicted that HinfI and either AatII
or AciI could be used for genomic typing with 99.4%
accuracy. cDNA sequencing and subsequent alignment of 21 Argentine GB
virus C/hepatitis G virus strains confirmed restriction fragment length polymorphism patterns theoretically predicted. This method may be
useful for a rapid screening of samples when either epidemiological or
transmission studies of this agent are carried out.
 |
INTRODUCTION |
GB virus C (GBV-C)/hepatitis G virus
(HGV) is a recently described agent which has been proposed as a member
of the Flaviviridae family, distantly related to GBV-A and
even more related to HCV (18, 33). The virus is able to
infect humans parenterally and vertically, although its true
pathogenicity is under extensive study (2, 22). Its viral
genome is a positive-strand RNA that appears to be approximately 9.4 kb
long and that includes a long open reading frame. Based on sequence
homology with HCV, it has been proposed that the predicted HGV
polyprotein contains two putative envelope proteins (E1 and E2), an RNA
helicase, a serine protease, and an RNA-dependent RNA polymerase
(18, 27). Initial suggestions of an apparent lack of core
coding region have very recently been challenged, when the expression
of sequences upstream of the E1 coding region was demonstrated
(41).
Sequence analysis of the most 5'-terminal region shows a certain degree
of heterogeneity among different isolates. Based on a study of 44 sequences from around the world, Muerhoff et al. (24)
initially proposed the existence of three genotypes, i.e., 1, 2, and 3, the first two including two subtypes each. When such analysis was
extended to a fragment of 374 nucleotides (nt) of the 5' untranslated
region (UTR) from 83 isolates, four groups, namely, 1, 2a, 2b, and 3, were finally established (23).
Up to now, at least two attempts have been made in order to provide a
rapid method for HGV typing (25, 29). However, the growing
number of HGV sequences deposited in the GenBank database and the
changing view regarding types and subtypes led us to improve our
initial method. To reach this goal, all so-called complete HGV
sequences deposited in GenBank at the time of submission of this
manuscript (n = 22) and partial sequences from the 5'
UTR were used for phylogenetic analysis and predictive restriction fragment length polymorphism (RFLP) patterns in this study. Since a
consensus nomenclature about GBV-C/HGV grouping and subgrouping is
still lacking and because the observed degree of genomic diversity at
5' UTR is not similarly represented within other genomic regions (34), we will use the terms group and subgroup instead
of type and subtype. In this study, we propose a rapid method for
GBV-C/HGV classification by 5' UTR cDNA amplification
followed by enzymatic cleavage to obtain group- and
subgroup-specific RFLP profiles.
 |
MATERIALS AND METHODS |
RNA extraction and cDNA synthesis.
RNA was initially
obtained from 200 µl of a reference plasma, PNF2161 (18),
kindly provided by Margaret Gallagher (Centers for Disease Control and
Prevention, Atlanta, Ga.). After reverse transcription (RT) and
amplification conditions were settled, serum samples from 100 parenterally HIV-infected patients were studied. RNA was obtained from
serum by guanidinium isothiocyanate-acidic phenol extraction
(5), as previously described (28). RT was performed by incubating the template (equivalent to 100 µl of serum)
in the presence of 200 pM outer antisense primer (GOA) 5' CCC GGC
CCC CAC TGG TCC TTG 3' and 200 U of Moloney murine leukemia virus
for 1 h at 37°C. Reverse transcriptase was inactivated by being
heated to 95°C for 10 min, and cDNA was kept cold until PCR
amplification, which was performed immediately.
PCR amplification.
An aliquot of cDNA was amplified in a
volume of 50 µl by using GOA and an outer sense primer (GOS) 5'
CGG CAC TGG GTG CAA GCC CCA 3'. After a denaturation step (2 min
30 s at 94°C), 35 cycles of PCR, with 1 cycle consisting of
denaturation (30 s at 94°C), annealing (30 s at 55°C), and primer
extension (45 s at 72°C), followed. Nested PCR was performed in a
volume of 50 µl after transfer of 5 µl from the first round of PCR
to a mix containing 200 pM inner sense primer (GIS, 5' AGC CCC AGA
AAC CGA CGC CTA 3') and an inner antisense primer (GIA, 5'
TAT TGG TCA AGA GAG ACA TTG 3'). This second PCR was performed
after a denaturation step as given above, followed by 40 cycles of PCR,
with 1 cycle consisting of denaturation (30 s at 94°C), annealing (30 s at 53°C), and extension (45 s at 72°C).
Amplicons of 325 to 329 bp were expected. Amplified sequences
corresponded to positions located from nt 10 to 335 (with eventual insertions of deletions) from the most extreme 5' UTR of GBV-C. Since this prototype strain appears to be 19 nt shorter than other isolates, another useful numbering method has been recently proposed by
Smith et al. (34), who propose decreasing negative values from the most 5' UTR nucleotide up to the last base before the first
(putatively assigned) coding AUG.
cDNA sequencing.
The specificity of the reaction was
assessed by direct sequencing of PCR amplicons. Briefly, 3 nested PCR
mixtures were pooled, purified in 7% polyacrylamide gels, eluted in
0.5 M NH4 acetate, 0.01 M EDTA, and 0.1% sodium dodecyl
sulfate, phenol-chloroform extracted, ethanol precipitated, and
resuspended in 10 µl of sterile distilled water. Manual and/or
automatic sequencing by the chain termination method (31)
was performed alternately with [
-32P]dATP-labelled GIS
or GIA primer or with either primer in the presence of fluorescent
dye-labelled chain terminators, respectively.
Molecular evolutionary genomic analysis.
Considering the
location and length (325 to 329 bp) of the above-mentioned predicted
amplicons, both reported complete (n = 120) and partial
5' UTR GBV-C/HGV sequences (n = 30) from GenBank, as
well as from virus-infected Argentine patients (n = 21), were included for alignment and phylogenetic analysis. An
initial phylogenetic analysis was performed on downloaded GenBank
sequences. DNA alignments were generated with the Clustal X program
(11, 13, 38). Evolutionary distances between sequences were
determined with the DNADIST program (Kimura two-parameter method) of
the PHYLIP package version 3.5c (8). The computed distances
were used for the construction of phylogenetic trees by the
neighbor-joining method of NEIGHBOR program. The robustness of the
trees was assessed by bootstrap resampling with the programs SEQBOOT
(to generate 1,000 reshuffled sequences), DNADIST, and NEIGHBOR. The
consensus tree was calculated with CONSENSE. Bootstrap values of less
than 70% were regarded as not providing strong support for the
phylogenetic grouping. The tree was obtained from RETREE program
(PHYLIP package) with the midpoint rooting option. Final graphical
output was created with the program TREEVIEW. The MapDraw program
(DNASTAR Package, Lasergene for Windows) was selected to detect group-
and subgroup-specific restriction sites.
Sequences deposited in GenBank database and used in the analysis are
shown in Table 1.
Nucleotide sequence accession numbers.
The following
sequences from GBV-C/HGV Argentine strains were deposited in
GenBank: AF081562, AF081564, AF116325, AF116326, AF116327, AF116328,
AF116329, AF116334, AF116335, AF116338, AF116339, AF116340, AF081561, AF116330, AF116332, AF116333, AF081563, AF116324, AF116331, AF116336,
and AF116337.
 |
RESULTS |
Molecular genomic GBV-C/HGV analysis and predicted RFLP
patterns.
In order to determine whether restriction sites of
GBV-C/HGV sequences deposited in the GenBank database
might be useful in distinguishing groups and subgroups,
150 5' UTR sequences discussed above were selected. Of the 150 sequences, 120 encompassed the complete length of 325 to 329 nt
extended between the 5' ends of GIS and GIA primers; 22 of them were
regarded as full-length genomic sequences. Another group of
30 sequences (AF006957 to AF006986) did not have the first 37 nt
(positions 10 to 46 according to the GBV-C numbering system) of our
amplified products. Consequently, our sequence alignment
used a fragment corresponding to positions 47 to 335, following
the GBV-C numbering system.
After sequence alignment, a phylogenetic tree was
constructed (Fig. 1). Three major
groups, one including two subgroups, were evident, namely, 1, 2a,
2b, and 3.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Phylogenetic tree of 290-nt 5' UTR sequences deposited
in GenBank. The GenBank accession numbers of the isolates are given in
Table 1. A distance scale (in nucleotide substitutions per position) is
shown.
|
|
Analysis of restriction sites of all the sequences showed that
endonucleases could be used in genomic typing and subtyping. Initial
cleavage with HinfI produces at least 10 different patterns, which we named H1, H2, H3, H4, H5, H6, H7, H8, H9, and H10 (Fig. 2). Partial sequences (about 290 bp long)
were also included and classified as compatible with a given pattern
(the pattern number followed by an asterisk). Group 1 was
associated with H1, H2, and H5 patterns; group 2 was associated with
H1, H3, or H3* (strong association), H4 or H4*, H6*, H8, H9, and H10
patterns; and group 3 was associated with H1 or H1* or infrequently
with H7 (Fig. 2).

View larger version (69K):
[in this window]
[in a new window]
|
FIG. 2.
Predicted RFLP patterns obtained by computer analysis of
150 5' UTR GBV-C/HGV sequences downloaded from GenBank. The 21 Argentine GBV-C/HGV sequences in this study also supported the proposed
RFLP method. RFLP patterns with an asterisk belong to 290-bp partial
sequences starting at position 47 according to the GBV-C numbering
system. The numbers under restriction fragment length polymorphism
indicate the expected sizes (in base pairs) of the fragments, and the
numbers of sequences with a given pattern in group or subgroup 1, 2a, 2b, and 3 and the total number (n) are shown.
|
|
Since H1 and H1* patterns were observed almost exclusively with either
group 1 or 3, sequences with these profiles were resolved by means of
AatII, taking into account that all such group 1 sequences (n = 18) were not cut, in contrast to all H1 and H1*
group 3 sequences (n = 29) which could be cleaved at
position 231 of the fragment (nt 241 from the most 5' terminal base)
(Fig. 2). Thus, computer-predicted RFLP with AatII of H1 or
H1*, H2, H5, or H7 sequences (whose HinfI RFLP profile was
compatible with group 1 and/or 3) allowed their segregation into either
group: 22 sequences were assigned to group 1 and the other 18 were
assigned to group 3 (Fig. 2). AciI cleavage allowed
subgroup 2a to be segregated from subgroup 2b; while all 2b
sequences (n = 12) were not cut, all 2a sequences
(n = 84) could be cleaved at several restriction sites
(Fig. 2).
RT-PCR amplification.
As a positive control, the specificity
of the designed primers was assessed when only products of the expected
size (no spurious bands) were observed after RT and subsequent
amplification of the RNA obtained from the reference plasma PNF2161
(U44402). This system also allowed the detection of GBV-C/HGV RNA in 21 of 100 parenterally HIV-infected patients.
RFLP and cDNA sequencing.
All Argentine isolates (n = 21) were grouped by the RFLP method described in this study.
GBV-C/HGV strains were classified as group 1, 2a, 2b, and 3. The
accuracy of the proposed methodology was subsequently substantiated by
cDNA sequencing, since the phylogenetic analysis of the sequences
obtained showed complete agreement with the observed RFLP
patterns from each sample (Fig. 3
and 4). GBV-C/HGV sequences from
Argentine strains deposited in GenBank, belonged to the following
groups: group 1, AF081562; subgroup 2a, AF081564, AF116325, AF116326, AF116327, AF116328, AF116329, AF116334, AF116335,
AF116338, AF116339, and AF116340; subgroup 2b, AF081561,
AF116330, AF116332, and AF116333; and group 3, AF081563,
AF116324, AF116331, AF116336, and AF116337.

View larger version (79K):
[in this window]
[in a new window]
|
FIG. 3.
RFLP characterization of GBV-C/HGV group 1 (lanes 4 and
5) and group 3 (lanes 2 and 3). AatII (lanes 2 and 4) or
HinfI (lanes 3 and 5) were used. Lane 1 contains 50-bp
ladder.
|
|

View larger version (64K):
[in this window]
[in a new window]
|
FIG. 4.
RFLP characterization of GBV-C/HGV 2a (lanes 4 and 5)
and 2b (lanes 2 and 3) subgroups. AciI (lanes 2 and 4)
and HinfI were used. Lane 1 contains 50-bp ladder.
|
|
In agreement with a previous study (23), reference sample
PNF2161 was classified as a member of group 2a by phylogenetic analysis. Its predicted group 2a RFLP profile was also
confirmed by gel electrophoresis.
Within group 2, two unusual sequences were observed among
Argentine samples with GenBank accession nos. AF116327 and
AF116340, which showed a G at position 166, leading to the loss of a
HinfI restriction site. These isolates were classified as
group 2a by both RFLP and sequence alignment with previously
characterized isolates. Their unusual sequences showed 100% homology
with a rare GBV-C/HGV variant downloaded from GenBank (sequence
AF006961).
Phylogenetic analysis.
Three major groups, i.e., 1, 2 (including two subgroups) and 3 were observed (Fig. 1). This result
was substantiated after 1,000 replicates for bootstrap analysis.
Grouping into subgroups 2a and 2b was undoubtedly supported by
70 and 93% of all trees, respectively. In contrast, no sufficient
support was observed for subgroups within group 1 (45 and 86% for
the two observed branches) with the sole exception of sequence AF078048
from Singapore (40) which might represent a different
(sub)group. RFLP profile from this sequence is shown among
AatII restriction patterns in Fig. 2, followed by a
"?" and in the phylogenetic tree from Fig. 1 as sequence 149.
 |
DISCUSSION |
Our sequence alignment confirmed isolate grouping of
GBV-C/HGV strains included in a recently reported study
by analysis of a partially overlapping 374-nt region (positions 79 to 447).
Considering all 150 sequences, three major groups (i.e., 1, 2 [including two subgroups], and 3) were observed as depicted in
Fig. 1.
The initial visual and computational analyses, including both their
alignment and phylogenetic relatedness, of 94 sequences allowed the
detection of conserved regions to design universal primers, as
well as group- and subgroup-specific restriction sites. When
extended to additional 56 sequences (total number, 150) the same
clustering was observed, although a few more RFLP patterns were
evident. Although not closely related to other group 2a strains, sequence analysis of the reference isolate PNF2161 also supported the
proposed methodology. Moreover, cDNA sequencing of 21 Argentine isolates confirmed GBV-C/HGV typing based on 5' UTR RFLP (data not shown).
Interestingly, sequence U75356 (Chinese isolate HGVC964
[44]) was putatively assigned to group 2a or 3 according to the length and subregion location analyzed at 5' UTR
(23) (not included in the phylogenetic analysis shown). It
was classified into a separate group by another phylogenetic tree when
we analyzed its sequence, associated with the observed insertion of
three consecutive nucleotides (data not shown). This sequence exhibited
the predicted group 3 RFLP pattern, also in agreement with an analysis
of its artificially combined E2-NS3-NS5b genome (23).
Subsequently, sequence U75356 was described as the unique example of a
putative genotype 4 by Smith et al. (34).
At least three items deserve special comments. First, although to a
lesser extent than with 5' UTR HCV isolates (since genetic distances
between GBV-C/HGV groups are most similar to those observed between HCV
subtypes) GBV-C/HGV strains show sufficient heterogeneity to allow
their clustering in at least three major groups, group 2 including two
subgroups and group 1 possibly including at least one sequence
(sequence 149 [Fig. 1]) clustered separately. Considering that such
low level of heterogeneity might signify minor changes at
the amino acid level in coding regions, antigenic diversity would
seem to be unlikely reflected in clinical or biological differences of
this viral infection. However, the effects of mutations at 5' UTR
should be thoroughly investigated, since significant differences of
biological properties could be associated with them, as has been
shown with other viruses, i.e. poliovirus, HCV, etc. Second, of
150 previously reported sequences and of the 21 Argentine isolates
shown here, almost no discrepancies between phylogenetic and RFLP
analyses of the 5' UTR were observed with the unique exception of
sequence AF078048 (40) which clustered with genogroup 1 but
exhibited a group 3 RFLP profile (Fig. 1 and 2). As stated above, this
isolate might represent a new (sub)group. Third, regarding a putative
geographical distribution of genogroups, it should be noted that all
groups and subgroups were observed in Argentine patients. These
results extend the initial observations of Muerhoff et al, who
documented the existence of two 2a and one 2b isolate from
Argentina (23). GBV-C/HGV genotypic prevalence in Argentine
patients and blood donors will be published elsewhere.
Based on a recent report showing that a 374-nt sequence from the 5' UTR
truly represents differences in the whole genome (23), the
methodology described here might be useful for a rapid screening of
GBV-C/HGV isolates when epidemiological studies are undertaken. Indeed,
selected 5' UTR regions from both studies partially overlap. Furthermore, another recent study also supports the use of the 5' UTR
for GBV-C/HGV grouping (34). Mukaide et al. have also proposed RFLP typing of GBV-C/HGV variants based on the phylogenetic study of shorter 5' UTR sequences (183 nt). However, their analysis of 33 sequences was unable to substantiate group 2 subgrouping (25). Moreover, when we analyzed Argentine sequence
AF116331, its phylogenetic grouping showed that it belongs to
group 3, as also exhibited by our RFLP method (restriction
patterns H1 and Aa2). However, according to the previously
mentioned procedure (25), it should have been classified as
HG type, assumed to correspond to group 2 following Muerhoff's
nomenclature (23). Likewise, recently available
sequences downloaded from GenBank (i.e., AF038810 to AF038814 and
Y15266) exhibit RFLP patterns not initially described by Mukaide
et al. In this regard, it should be stressed that other
researchers have demonstrated that only sequences that are long
enough could be used to properly perform phylogenetic analysis to
obtain reliable data (23, 34).
In our proposed method, the use of GIS primer allowed the eventual
detection of a HinfI cleavage site at position 38 of a given
amplicon (nt 48 according to the GBV-C numbering system). Such a site
appeared to be important to detect a high percentage of genogroup 2 sequences, while group 2 subgrouping is consistently determined by
AciI digestion (Fig. 2). However, among 84 group 2a
sequences downloaded from GenBank and characterized by phylogenetic relationships supported by bootstrap analysis, two (accession nos. AF038812 and AF038813; [20]) deserve special
comments. These two sequences are shown with a dagger symbol in
Fig. 2 among sequences producing H1 (HinfI) and Aa1
(AatII) restriction patterns. Therefore, such a profile is
compatible with genotype 1. For properly assigning genogroup to these
two unusual sequences, it was necessary to perform also
AciI digestion, where an Ac2 pattern was observed, in
contrast to all genuine group 1 sequences where this profile was not
documented (n = 22).
A proposed algorithm of enzyme digestions is shown in Fig.
5. We suggest initially cleaving
amplicons with HinfI. According to the pattern
observed (H1 to H10), subsequent digestions could be performed
either with AatII (usually to distinguish between groups 1 and 3) and AciI to differentiate subgroups 2a and
2b. From a practical point of view, the two subgroup 2a
sequences discussed above, AF038812 and AF038813, appeared to add a
third step in the algorithm of digestions to distinguish between group 1 and group 3 [i.e., (i) HinfI, (ii)
AatII, and (iii) AciI]. However, it is worth
mentioning that these two sequences belong to a single isolate (called
S4) from which five clones were analyzed, only two (clones 4 and 5)
showing the loss of a HinfI site due to the presence of a C
at position 157, instead of G (20). Therefore, the
possibility of picking an RT-PCR amplification error or the detection
of nonpredominant quasispecies cannot be ruled out. Whether such
sequences truly represent a feature from a proportion of Spanish
patients remains to be determined. This methodology allowed proper
assignment of 149 of 150 sequences downloaded from GenBank and 21 of 21 Argentine strains (n = 171; 99.4% accuracy).
With regard to other sequences not included in this study, it should be
mentioned that those entire polyprotein open reading frame
sequences (AB003291 and AB003292) proposed to be new genotypes
(36) could not be analyzed, since information about their
sequence at 5' UTR does not show 111 nt from the most 5' end of the
corresponding amplicon of our study. A similar exclusion criteria
with
variable lengths in the region to be analyzed
was used for other
several sequences (1, 21, 44).
To be useful, a typing method based initially on RT-PCR detection of
genomic sequences must be able to detect most, if not all,
strains. Therefore, universal primers are usually selected from
conserved regions. This was the case when we initially designed primers
used in this method. However, the increasing number of GBV-C/HGV
sequences deposited in GenBank demonstrated that few mismatches were
evident with some sequences. This appeared to be a problem with
sequences like AF015870 to AF015872 and AF015876 to AF015878
(43) for which GOS primer exhibits a mismatch at its 3' end.
Potential inefficacy in the RT-PCR amplification might be overcome by
using primers with ambiguities at the critical nucleotide positions. As
can be observed by visual and computer analyses, the mismatch at the
most 3' end of the outer sense primer would be crucial to hybridize the
cDNA synthesized by extension from the 3' end of the antisense primer,
as shown in Fig. 6.
At first glance, it would appear that sense primer cannot
efficiently amplify sequences like AF015870 to AF015872 and other
related sequences. However, Kwok et al. (15) have elegantly demonstrated that this is not the case. They unambiguously demonstrated by experiments done in triplicate that despite an A at the 3' end of a
primer, efficiency of amplification is 100% when the corresponding
position at the template is occupied by a C. This effect is reciprocal
(either the mismatch is in the template or in the primer). This
research group, among many others, have also observed that a single
internal mismatch (as very unfrequently observed with few GBV-C/HGV
sequences) does not significantly affect yield of amplification
(15, 35).
So far, whether GBV-C/HGV sequence variability influences the course of
infection is unknown. However, such variation has been associated with
a different outcome with the related HCV (3). In this
regard, Japanese (42) and German (10) researchers have reported strain-specific association with fulminant hepatitis. Although such findings were not subsequently extended, the recent discovery of GBV-C/HGV in bone marrow, spleen, and liver
(16) deserves thorough studies regarding cell tropism and
potential influence of viral genomic variations in the
infection of such tissues. While newly discovered sequences will
probably warrant periodical updating of the proposed methodology, this
study also contributes to the knowledge of the molecular epidemiology
of viral hepatitis in Argentina (28, 30, 37).
 |
ACKNOWLEDGMENTS |
This study was partly supported by grants from University of
Buenos Aires (ME/009) and CONICET (PIP 6554), Argentina.
We are truly indebted to Betty H. Robertson and Margaret Gallagher
(Centers for Disease Control and Prevention) for providing an aliquot
of the reference plasma PNF2161 and to Osvaldo Libonatti and Mirna
Biglione for kindly providing most of the HIV-infected sera.
 |
ADDENDUM IN PROOF |
While this article was in press, a related paper was published
by J. M. López-Alcorocho, I. Castillo, J. F. Tomas,
and I. Carreño (J. Med. Virol. 57:80-84, 1999).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Departamento
Microbiología, Facultad de Medicina, Universidad de Buenos
Aires, Paraguay 2155, Piso 11, (1121) Buenos Aires, Argentina. Phone:
54-11-4508-3689. Fax: 54-11-4508-3705. E-mail:
j_oubina{at}hotmail.com.
 |
REFERENCES |
| 1.
| Abe, K., and T. Kaneko. 1997. Unpublished
data.
|
| 2.
|
Alter, H.
1996.
The cloning and clinical implications of HGV and HGBV-C.
N. Engl. J. Med.
334:1536-1537[Free Full Text].
|
| 3.
|
Amoroso, P.,
M. Rapicetta,
M. E. Tosti,
A. Mele,
E. Spada,
S. Buonocore,
G. Lettieri,
P. Pierri,
P. Chionne,
A. R. Ciccaglione, and L. Sagliocca.
1998.
Correlation between virus genotype and chronicity rate in acute hepatitis.
C. J. Hepatol.
28:939-944.
[Medline] |
| 4.
|
Bukh, J.,
J. P. Kim,
S. Govindarajan,
C. L. Apgar,
S. K. H. Foung,
J. Wages,
J. A. Yun,
M. Shapiro,
S. U. Emerson, and R. H. Purcell.
1998.
Experimental infection of chimpanzees with hepatitis G virus and genetic analysis of the virus.
J. Infect. Dis.
177:855-862[Medline].
|
| 5.
|
Chomczynski, P., and N. Sacchi.
1987.
Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:156-159[Medline].
|
| 6.
|
Christopherson, C.,
J. Sninsky, and S. Kwok.
1997.
The effects of internal primer-template mismatches on RT-PCR: HIV-1 model studies.
Nucleic Acids Res.
25:654-658[Abstract/Free Full Text].
|
| 7.
|
Erker, J. C.,
J. N. Simons,
A. S. Muerhoff,
T. P. Leary,
M. L. Chalmers,
S. M. Desai, and I. K. Mushahwar.
1996.
Molecular cloning and characterization of a GB virus C isolate from a patient with non-A-E hepatitis.
J. Gen. Virol.
77:2713-2720[Abstract/Free Full Text].
|
| 8.
|
Felsenstein, J.
1993.
PHYLIP inference package, version 3.5c.
University of Washington, Seattle.
|
| 9.
|
Fukushi, S.,
C. Kurihara,
N. Ishiyama,
H. Okamura,
F. B. Hoshino,
A. Oya, and K. Katayama.
1996.
Nucleotide sequence of the 5' non-coding region of hepatitis G virus isolated from Japanese patients: comparison with reported isolates.
Biochem. Biophys. Res. Commun.
226:314-318[Medline].
|
| 10.
|
Heringlake, S.,
S. Osterkamp,
C. Trautwein,
H. L. Tillmann,
K. Böker,
S. Muerhoff,
I. K. Mushahwar,
G. Hunsmann, and M. P. Manns.
1996.
Association between fulminant hepatic failure and a strain of GBV virus C.
Lancet
348:1626-1629[Medline].
|
| 11.
|
Higgins, D. G.,
A. J. Bleasby, and R. Fuchs.
1992.
Clustal V: improved software for multiple sequence alignment.
Comput. Appl. Biosci.
8:189-191[Abstract/Free Full Text].
|
| 12.
|
Hsieh, S. Y.,
P. Y. Yang,
H. C. Chen, and Y. F. Liaw.
1997.
Cloning and characterization of the extreme 5'-terminal sequences of the RNA genomes of GB virus C/hepatitis G virus.
Proc. Natl. Acad. Sci. USA
94:3206-3210[Abstract/Free Full Text].
|
| 13.
|
Jeanmougin, F.,
J. D. Thompson,
M. Gouy,
D. G. Higgins, and T. J. Gibson.
1998.
Multiple sequence alignment with Clustal X.
Trends Biochem. Sci.
23:403-405[Medline].
|
| 14.
|
Katayama, K.,
S. Fukushi,
C. Kurihara,
N. Ishiyama,
H. Okamura,
F. B. Hoshino, and A. Oya.
1998.
Full-length GBV-C/HGV genomes from nine Japanese isolates: characterization by comparative analyses.
Arch. Virol.
143:1-13[Medline].
|
| 15.
|
Kwok, S.,
D. E. Kellogg,
N. McKinney,
D. Spasic,
L. Goda,
C. Levenson, and J. J. Sninsky.
1990.
Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies.
Nucleic Acids Res.
18:999-1005[Abstract/Free Full Text].
|
| 16.
|
Laskus, T.,
M. Radkowski,
L.-F. Wang,
H. Vargas, and J. Rakela.
1998.
Detection of hepatitis G virus replication sites by using highly strand-specific Tth-based reverse transcriptase PCR.
J. Virol.
72:3072-3075[Abstract/Free Full Text].
|
| 17.
|
Linnen, J. M.,
K. Fung,
K. E. Fry,
M. Mizokami,
K. Ohba,
J. M. Wages, Jr.,
Z.-Y. Zhang-Keck,
K. Song, and J. P. Kim.
1997.
Sequence variation and phylogenetic analysis of the 5' terminus of hepatitis G virus.
J. Viral Hepatitis
4:293-302[Medline].
|
| 18.
|
Linnen, J.,
J. Wages, Jr.,
Z.-Y. Zhang-Keck,
K. E. Fry,
K. Z. Krawczynski,
H. Alter,
E. Koonin,
M. Gallagher,
M. Alter,
S. Hadziyannis,
P. Karayiannis,
K. Fung,
Y. Nakatsuji,
J. W.-K. Shih,
L. Young,
M. Piatak, Jr.,
C. Hoover,
J. Fernández,
S. Chen,
J.-C. Zou,
T. Morris,
K. C. Hyams,
S. Ismay,
J. D. Lifson,
G. Hess,
S. K. H. Foung,
H. Thomas,
D. Bradley,
H. Margolis, and J. P. Kim.
1996.
Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent.
Science
271:505-508[Abstract].
|
| 19.
|
Liu, H. F.,
C. Cornu,
M. Jadoul,
K. Dahan,
G. Loute, and P. Goubau.
1998.
Molecular analysis of GB virus C isolates in Belgian hemodialysis patients.
J. Med. Virol.
55:118-122[Medline].
|
| 20.
| López-Alcorocho, J. M., I. Castillo, J. F. Tomas, and V. Carreño. Unpublished data.
|
| 21.
| Lu, L., S. W. K. Im, M. H. Ng, and
Y. S. Fu. Unpublished data.
|
| 22.
|
Miyakawa, Y., and M. Mayumi.
1997.
Hepatitis G virus: a true hepatitis virus or an accidental tourist?
N. Engl. J. Med.
336:795-796[Free Full Text].
|
| 23.
|
Muerhoff, A. S.,
D. B. Smith,
T. P. Leary,
J. C. Erker,
S. M. Desai, and I. K. Mushahwar.
1997.
Identification of GB virus C variants by phylogenetic analysis of 5' untranslated and coding region sequences.
J. Virol.
71:6501-6508[Abstract].
|
| 24.
|
Muerhoff, A. S.,
J. N. Simons,
T. P. Leary,
J. C. Erker,
M. L. Chalmers,
T. J. Pilot-Matías,
G. J. Dawson,
S. M. Desai, and I. K. Mushahwar.
1996.
Sequence heterogeneity within the 5'-terminal region of the hepatitis GB virus C genome and evidence for genotypes.
J. Hepatol.
25:379-384[Medline].
|
| 25.
|
Mukaide, M.,
M. Mizokami,
E. Orito,
K. Ohba,
T. Nakano,
R. Ueda,
K. Hikiji,
S. Iino,
S. Shapiro,
N. Lahat,
Y.-M. Park,
B.-S. Kim,
T. Oyunsuren,
M. Rezieg,
M. N. Al-Ahdal, and J. Y. N. Lau.
1997.
Three different GB virus C/hepatitis G virus genotypes. Phylogenetic analysis and a genotyping assay based on restriction fragment length polymorphism.
FEBS Lett.
407:51-58[Medline].
|
| 26.
|
Nakao, H.,
H. Okamoto,
M. Fukuda,
F. Tsuda,
T. Mitsui,
K. Masuko,
H. Iizuka,
Y. Miyakawa, and M. Mayumi.
1997.
Mutation rate of GB virus C/hepatitis G virus over the entire genome and in subgenomic regions.
Virology
233:43-50[Medline].
|
| 27.
|
Okamoto, H.,
H. Nakao,
T. Inoue,
M. Fukuda,
J. Kishimoto,
H. Iizuka,
F. Tsuda,
Y. Miyakawa, and M. Mayumi.
1997.
The entire nucleotide sequence of two GB virus C/hepatitis G virus isolates of distinct genotypes from Japan.
J. Gen. Virol.
78:737-745[Abstract].
|
| 28.
|
Oubiña, J. R.,
J. F. Quarleri,
M. Rudzinski,
C. Parks,
I. Badía, and S. M. González Cappa.
1995.
Genomic characterization of hepatitis C virus isolates from Argentina.
J. Med. Virol.
47:97-104[Medline].
|
| 29.
|
Quarleri, J. F., and J. R. Oubiña.
1997.
A proposed rapid method for genomic characterization of GBV-C/hepatitis G virus (HGV).
Medicina (Buenos Aires)
57:717-719.
|
| 30.
|
Quarleri, J. F.,
B. H. Robertson,
V. Mathet,
S. D. Sinha,
I. Badía,
B. Frider,
A. Ferro,
C. Galoppo,
S. Sookoian,
G. Castaño, and J. R. Oubiña.
1998.
Genomic and phylogenetic analysis of hepatitis C virus strains from Argentina.
Medicina (Buenos Aires)
58:153-159.
|
| 31.
|
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 32.
|
Shao, L.,
H. Shinzawa,
K. Ishikawa,
X. Zhang,
M. Ishibashi,
H. Misawa,
N. Yamada,
H. Togashi, and T. Takahashi.
1996.
Sequence of hepatitis G virus genome isolated from a Japanese patient with non-A-E-hepatitis: amplification and cloning by long reverse transcription-PCR.
Biochem. Biophys. Res. Commun.
228:785-791[Medline].
|
| 33.
|
Simons, J. N.,
T. P. Leary,
G. J. Dawson,
T. J. Pilot-Matías,
A. S. Muerhoff,
G. G. Schlauder,
S. M. Desai, and I. K. Mushahwar.
1995.
Isolation of novel virus-like sequences associated with human hepatitis.
Nature Med.
1:564-569[Medline].
|
| 34.
|
Smith, D. B.,
N. Cuceanu,
F. Davidson,
L. M. Jarvis,
J. L. K. Mokili,
S. Hamid,
C. A. Ludlam, and P. Simmonds.
1997.
Discrimination of hepatitis G virus/GBV-C geographical variants by analysis of the 5' non-coding region.
J. Gen. Virol.
78:1533-1542[Abstract].
|
| 35.
|
Sommer, R., and D. Tautz.
1989.
Minimal homology requirements for PCR primers.
Nucleic Acids Res.
17:6749[Free Full Text].
|
| 36.
|
Takahashi, K.,
M. Hijikata,
K. Hino, and S. Mishiro.
1997.
Entire polyprotein-ORF sequences of Japanese GBV-C/HGV isolates: implications for new genotypes.
Hepatol. Res.
8:139-148.
|
| 37.
|
Telenta, P. F. S.,
G. Palacios Poggio,
J. L. López,
J. González,
A. Lemberg, and R. H. Campos.
1997.
Increased prevalence of genotype F hepatitis B virus isolates in Buenos Aires, Argentina.
J. Clin. Microbiol.
35:1873-1875[Abstract].
|
| 38.
|
Thompson, J. D.,
T. J. Gibson,
F. Plewniak,
F. Jeanmougin, and D. G. Higgins.
1997.
The CLUSTAL X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.
Nucleic Acids Res.
25:4876-4882[Abstract/Free Full Text].
|
| 39.
|
Wang, H. L., and D.-Y. Jin.
1997.
Prevalence and genotype of hepatitis G virus in Chinese professional blood donors and hepatitis patients.
J. Infect. Dis.
175:1229-1233[Medline].
|
| 40.
| Wong, J., S. H. Chan, and E. C. Ren.
Unpublished data.
|
| 41.
|
Xiang, J.,
D. Klinzman,
J. McLinden,
W. N. Schmidt,
D. R. LaBrecque,
R. Gish, and J. T. Stapleton.
1998.
Characterization of hepatitis G virus (GB-C virus) particles: evidence for a nucleocapsid and expression of sequences upstream of the E1 protein.
J. Virol.
72:2738-2744[Abstract/Free Full Text].
|
| 42.
|
Yoshiba, M.,
H. Okamoto, and S. Mishiro.
1995.
Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology.
Lancet
346:1131-1132[Medline].
|
| 43.
| Zanella, I., G. Fiordalisi, A. Bettinardi, M. Roncini,
R. Stellini, and D. Primi. Unpublished data.
|
| 44.
|
Zhou, Y. S.,
W. Chen,
Q. M. Zhao,
H. L. Zhao,
J. S. Zhang,
J. Xu, and H. T. Wang.
1996.
cDNA cloning and sequencing of HGV genome from Chinese.
Bull. Acad. Mil. Med. Sci.
20:249-253.
|
| 45.
|
Zhu, F. L.,
Z. T. Qi, and L. Shao.
1998.
Splicing and cloning of the full length genomic cDNA of GB virus C/hepatitis G virus.
Ti Erh Chun Ta Hsueh Hsueh Pao
19:301-306.
|
Journal of Clinical Microbiology, May 1999, p. 1340-1347, Vol. 37, No. 5
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Mathet, V. L., Espinola, L., Ruiz, V., Marincola, A., Quarleri, J. F., Ceballos, A., Peralta, L. A. M., Natal, M., Haedo, A., Sanchez, D. O., Oubina, J. R.
(2003). Phylogenetic and Mathematical Analyses for Investigating Putative Mother-to-Infant Transmission Chains When Only GB Virus C (Hepatitis G Virus) 5' Noncoding Region Sequences Are Available. J. Clin. Microbiol.
41: 4489-4491
[Full Text]
-
Quarleri, J. F., Robertson, B. H., Mathet, V. L., Feld, M., Espínola, L., Requeijo, M. P., Mandó, O., Carballal, G., Oubiña, J. R.
(2000). Genomic and Phylogenetic Analysis of Hepatitis C Virus Isolates from Argentine Patients: a Six-Year Retrospective Study. J. Clin. Microbiol.
38: 4560-4568
[Abstract]
[Full Text]